Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Falzone

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of <sup>90</sup>Y SIRT in Colorectal Cancer PatientsElliot M Abbott, Nadia Falzone, Boon Q Lee, et al.
Neuro-Oncology|September 21, 2019
VCAM-1 targeted alpha-particle therapy for early brain metastasesAurélien Corroyer-Dulmont, Samuel Valable, Nadia Falzone, et al.
Frontiers in Oncology|September 10, 2021
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of ChoiceAurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2017
Improved outcome of <sup>131</sup>I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastomaAurélien Corroyer-Dulmont, Nadia Falzone, Veerle Kersemans, et al.
Nuclear Medicine Communications|January 28, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastomaSally L George, Nadia Falzone, Sarah Chittenden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 2019
Imaging DNA Damage Repair In Vivo After <sup>177</sup>Lu-DOTATATE TherapyEdward O'Neill, Veerle Kersemans, P Danny Allen, et al.
Theranostics|January 2, 2018
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastasesNadia Falzone, Nicole L Ackerman, Liset de la Fuente Rosales, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
OpenDose: Open-Access Resource for Nuclear Medicine DosimetryMaxime Chauvin, Damian Borys, Francesca Botta, et al.
Plos One|April 29, 2017
An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouseVeerle Kersemans, John S Beech, Stuart Gilchrist, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of <sup>90</sup>Y SIRT in Colorectal Cancer PatientsElliot M Abbott, Nadia Falzone, Boon Q Lee, et al.
Neuro-Oncology|September 21, 2019
VCAM-1 targeted alpha-particle therapy for early brain metastasesAurélien Corroyer-Dulmont, Samuel Valable, Nadia Falzone, et al.
Frontiers in Oncology|September 10, 2021
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of ChoiceAurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2017
Improved outcome of <sup>131</sup>I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastomaAurélien Corroyer-Dulmont, Nadia Falzone, Veerle Kersemans, et al.
Nuclear Medicine Communications|January 28, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastomaSally L George, Nadia Falzone, Sarah Chittenden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 2019
Imaging DNA Damage Repair In Vivo After <sup>177</sup>Lu-DOTATATE TherapyEdward O'Neill, Veerle Kersemans, P Danny Allen, et al.
Theranostics|January 2, 2018
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastasesNadia Falzone, Nicole L Ackerman, Liset de la Fuente Rosales, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
OpenDose: Open-Access Resource for Nuclear Medicine DosimetryMaxime Chauvin, Damian Borys, Francesca Botta, et al.
Plos One|April 29, 2017
An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouseVeerle Kersemans, John S Beech, Stuart Gilchrist, et al.
Pageof 4